Yan Li to Losartan
This is a "connection" page, showing publications Yan Li has written about Losartan.
Connection Strength
1.020
-
Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. Kidney Int. 2010 Jun; 77(11):1000-9.
Score: 0.355
-
Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. Am J Physiol Renal Physiol. 2009 Sep; 297(3):F791-801.
Score: 0.338
-
Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system. J Am Soc Nephrol. 2010 Jun; 21(6):966-73.
Score: 0.089
-
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci U S A. 2008 Oct 14; 105(41):15896-901.
Score: 0.081
-
Loss of vitamin D receptor produces polyuria by increasing thirst. J Am Soc Nephrol. 2008 Dec; 19(12):2396-405.
Score: 0.081
-
Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice. Am J Physiol Regul Integr Comp Physiol. 2003 Jul; 285(1):R255-61.
Score: 0.055
-
Angiotensin II directly regulates intestinal epithelial NHE3 in Caco2BBE cells. BMC Physiol. 2009 Apr 01; 9:5.
Score: 0.021